- Zacks•1 hour ago
Johnson & Johnson (JNJ) announced that the French health authority has granted approval to expand the label of Eprex to include treatment of symptomatic anaemia in patients with low or intermediate risk myelodysplastic syndromes (MDS).
- Motley Fool•2 hours ago
No tending needed for big pharma stocks Johnson & Johnson, Pfizer, and Novartis.
- Bloomberg•7 hours ago
Companies hate losing their star workaholics, so J&J is triple-teaming them with a dietitian, a physiologist, and an executive coach.
JNJ : Summary for Johnson & Johnson Common Stock - Yahoo Finance
Johnson & Johnson (JNJ)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||125.15 - 126.14|
|52 Week Range||107.69 - 129.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.20|
|Dividend & Yield||3.20 (2.55%)|
|1y Target Est||N/A|